Escalon Medical (NASDAQ:ESMC) Climbs 24% in Pre-Market


Escalon Medical (NASDAQ:ESMC) is climbing higher in pre-market trading after the company said it received U.S. Food and Drug Administration (FDA) 510(k) clearance for its new tablet-based ultrasound imaging system, the Sonomed Escalon VuPad.  Shares are up 24.18% at $1.90, with a 52-week range of $1.01 – $2.59.  The VuPad is a portable ultrasound device which combines Sonomed Escalon’s UBM and B-scan image quality with an ultra-high-resolution screen that has 25% larger viewing area than other portable ultrasound devices.  The company anticipates immediate shipments of VuPad systems as orders are received and manufacturing ramps up to meet demand. CE marking and clearance by other international regulatory bodies is anticipated in the coming months.

In Other Pre-Market News:

USA Technologies (NASDAQ:USAT) shares jumped in Friday’s pre-market session, after the provider of technology-enabled systems that facilitate electronic-payment transactions said it entered a new, three-year exclusive agreement with the Pepi Cos. that it said “substantially expands” their existing relationship.  USAT was up 8.4% at $2.19 in recent pre-market trading, in a 52-week range of $1.40 to $2.60.  The company noted Pepi is an Alabama-based food, coffee and vending service provider that was its first customer to initiate a complete conversion to cashless payment and telemetry on its vending machines, a project completed at the end of 2012.
The new agreement leverages Pepi’s existing cashless-enabled vending network and USAT’s new Integrated Payment Services, an evolution of USAT’s ePort Connect service. Financial terms weren’t disclosed.

Suggested Reading: Poorest States in America